28 related articles for article (PubMed ID: 28342240)
1. Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival.
Alderdice M; Dunne PD; Cole AJ; O'Reilly PG; McArt DG; Bingham V; Fuchs MA; McQuaid S; Loughrey MB; Murray GI; Samuel LM; Lawler M; Wilson RH; Salto-Tellez M; Coyle VM
Mod Pathol; 2017 Sep; 30(9):1287-1298. PubMed ID: 28621318
[TBL] [Abstract][Full Text] [Related]
2. PTEN and P-4E-BP1 might be associated with postoperative recurrence of rectal cancer patients undergoing concurrent radiochemotherapy.
Zhang H; Li X; Sun W; Qin H; Li H; Yan H; Wang H; Zhang X; Zhang S; Wang H
BMC Cancer; 2024 May; 24(1):582. PubMed ID: 38741069
[TBL] [Abstract][Full Text] [Related]
3. p21 as a Predictor and Prognostic Indicator of Clinical Outcome in Rectal Cancer Patients.
Ooi LC; Ho V; Zhu JZ; Lim S; Chung L; Abubakar A; Rutland T; Chua W; Ng W; Lee M; Morgan M; MacKenzie S; Lee CS
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255799
[TBL] [Abstract][Full Text] [Related]
4. A distinct role for Lgr5
de Sousa e Melo F; Kurtova AV; Harnoss JM; Kljavin N; Hoeck JD; Hung J; Anderson JE; Storm EE; Modrusan Z; Koeppen H; Dijkgraaf GJ; Piskol R; de Sauvage FJ
Nature; 2017 Mar; 543(7647):676-680. PubMed ID: 28358093
[TBL] [Abstract][Full Text] [Related]
5. The Granulocyte-to-Lymphocyte Ratio as a Marker of Surgical Stress and a Predictor of Postoperative Infectious Complications After Gastric Cancer Surgery: An Analysis of Patients Enrolled in a Prospective Randomized Trial.
Lu J; Liu H; Cao LL; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Lin M; Tu RH; Li GX; Huang CM
Ann Surg Oncol; 2017 Sep; 24(9):2688-2697. PubMed ID: 28357673
[TBL] [Abstract][Full Text] [Related]
6. Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis.
Zhang H; Deng T; Liu R; Bai M; Zhou L; Wang X; Li S; Wang X; Yang H; Li J; Ning T; Huang D; Li H; Zhang L; Ying G; Ba Y
Nat Commun; 2017 Apr; 8():15016. PubMed ID: 28393839
[TBL] [Abstract][Full Text] [Related]
7. Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy.
Trotsyuk I; Sparschuh H; Müller AJ; Neumann K; Kruschewski M; Horst D; Elezkurtaj S
BMC Cancer; 2019 Nov; 19(1):1033. PubMed ID: 31675950
[TBL] [Abstract][Full Text] [Related]
8. The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
Jäger T; Neureiter D; Fallaha M; Schredl P; Kiesslich T; Urbas R; Klieser E; Holzinger J; Sedlmayer F; Emmanuel K; Dinnewitzer A
Strahlenther Onkol; 2018 Nov; 194(11):991-1006. PubMed ID: 30069738
[TBL] [Abstract][Full Text] [Related]
9. Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy.
Langer R; Becker K
Virchows Arch; 2018 Feb; 472(2):175-186. PubMed ID: 28918544
[TBL] [Abstract][Full Text] [Related]
10. Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment.
Thies S; Langer R
Front Oncol; 2013 Oct; 3():262. PubMed ID: 24109590
[TBL] [Abstract][Full Text] [Related]
11. Combination of growth pattern and tumor regression identifies a high-risk group in neoadjuvant treated rectal cancer patients.
Jessberger J; Erlenbach-Wünsch K; Posselt R; Haderlein M; Agaimy A; Fietkau R; Hartmann A; Distel L
J Dig Dis; 2017 May; 18(5):283-291. PubMed ID: 28342240
[TBL] [Abstract][Full Text] [Related]
12. Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.
Sprenger T; Conradi LC; Beissbarth T; Ermert H; Homayounfar K; Middel P; Rüschoff J; Wolff HA; Schüler P; Ghadimi BM; Rödel C; Becker H; Rödel F; Liersch T
Cancer; 2013 Jan; 119(1):26-35. PubMed ID: 22736392
[TBL] [Abstract][Full Text] [Related]
13. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Reggiani Bonetti L; Lionti S; Domati F; Pagliani G; Mattioli E; Barresi V
Histopathology; 2017 Sep; 71(3):393-405. PubMed ID: 28425130
[TBL] [Abstract][Full Text] [Related]
14. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis.
Hecht M; Büttner-Herold M; Erlenbach-Wünsch K; Haderlein M; Croner R; Grützmann R; Hartmann A; Fietkau R; Distel LV
Eur J Cancer; 2016 Sep; 65():52-60. PubMed ID: 27468145
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
